Jade Biosciences, Inc. · NASDAQ:JBIO
Frazier Life Sciences Public Fund, L.P.'s stake in Jade Biosciences, Inc. fell to 4.20% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Frazier Life Sciences Public Fund, L.P.'s stake in Jade Biosciences, Inc. fell to 4.20%, 1,384,646 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 1,384,646
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 4.20% | 1,384,646 |
| FHMLSP, L.P. | 4.20% | 1,384,646 |
| FHMLSP, L.L.C. | 4.20% | 1,384,646 |
| Frazier Life Sciences X, L.P. | 0% | 9,488 |
| FHMLS X, L.P. | 0% | 9,488 |
| FHMLS X, L.L.C. | 0% | 9,488 |
| Frazier Life Sciences XI, L.P. | 0.10% | 19,146 |
| FHMLS XI, L.P. | 0.10% | 19,146 |
| FHMLS XI, L.L.C. | 0.10% | 19,146 |
| James N. Topper | 0% | 9,488 |
| Patrick J. Heron | 0% | 9,488 |
Source
Related
- Jade Biosciences, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2025
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · May 5, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026